BACKSTOP AND SUBSCRIPTION AGREEMENTBackstop and Subscription Agreement • May 2nd, 2019 • Bison Capital Acquisition Corp. • Pharmaceutical preparations • New York
This Backstop and Subscription Agreement (this “Agreement”), made as of May 1, 2019 by and among Bison Capital Acquisition Corp., a British Virgin Islands business company with limited liability, which prior to the consummation of the transactions contemplated by the Merger Agreement (as defined below), will domesticate as a Delaware corporation and, immediately thereafter will be known as “Xynomic Pharmaceuticals Holdings, Inc.” (the “Company”), and Yinglin Mark Xu (“Subscriber”), is intended to set forth certain representations, covenants and agreements among the Company and Subscriber, with respect to Subscriber’s acquisition of the Company’s ordinary shares of no par value (which will automatically convert into shares of common stock of the Company upon the Domestication as defined in the Merger Agreement, par value $0.0001 per share, the “Ordinary Shares”), for an aggregate consideration of up to Seven Million and Five Hundred Thousand One U.S. Dollars ($7,500,001), through such a
